Nautilus Advisors LLC

Position in AMGN — Amgen Inc

CIK 2083253 La Jolla, CA

Position in AMGN

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$741,621

+$274 QoQ

Shares Held

2,048

-2.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.73%

of 13F equity value

Holder Rank

#1,914

of 3,140 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Nautilus Advisors LLC holds $5,916,229 across 6 Drug Manufacturers - General names. AMGN ranks #4 (12.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	7,491	$1,885,035
2	JNJ	Johnson & Johnson	4,260	$1,081,912
3	GILD	Gilead Sciences, Inc.	7,021	$887,033
4	AMGN	Amgen Inc This page	2,048	$741,621
5	BMY	Bristol Myers Squibb Co	12,345	$711,318
6	LLY	ELI LILLY & Co	508	$609,310

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$741,621	2,048	-2.8%	Shares	Sole	2026-07-14
2026-03-31	$741,347	2,107	-1.5%	Shares	Sole	2026-04-17
2025-12-31	$700,116	2,139	-0.1%	Shares	Sole	2026-01-22
2025-09-30	$604,472	2,142	+1.5%	Shares	Sole	2025-11-12
2025-06-30	$589,133	2,110	-1.9%	Shares	Sole	2025-08-26
2025-03-31	$669,832	2,150	+5.9%	Shares	Sole	2025-08-26
2024-12-31	$529,099	2,030	—	Shares	Sole	2025-08-26
No filing history on record for this holder in this stock.